Oral contraceptive use and ovarian cancer case study answers Video
Clinical Pearls for Contraceptive Management of Women with Developmental DisabilitiesOral contraceptive use and ovarian cancer case study answers - congratulate, your
Stuvia-kopers hebben meer dan Zo weet je zeker dat je de beste documenten koopt! Je betaalt supersnel en eenmalig met iDeal, creditcard of Stuvia-tegoed voor de samenvatting. Zonder lidmaatschap. Samenvattingen worden geschreven voor en door anderen. Daarom zijn de samenvattingen altijd betrouwbaar en actueel. Zo kom je snel tot de kern! Welke taal heeft je voorkeur? Je staat op het punt een specifiek domein van Stuvia te bezoeken Nederland. Wil je de website in het Engels of Nederlands bezoeken?
oral contraceptive use and ovarian cancer case study answers.
Oral contraceptives can reduce the risk of ovarian cancer, but the eventual public-health effects of this reduction will depend on how long the protection lasts after use ceases.
We aimed to assess these effects. METHODS: Individual data for 23, women with ovarian cancer cases and 87, without ovarian cancer controls from 45 epidemiological studies in 21 countries were checked and analysed centrally.
Voordelen van het kopen van samenvattingen bij Stuvia op een rij:
The relative risk of ovarian cancer in relation to oral contraceptive use was estimated, stratifying by study, age, parity, and hysterectomy. The median year of cancer diagnosis waswhen cases were aged an average of 56 years. The here that women had used oral contraceptives, the greater the reduction ovatian ovarian cancer risk p. These findings suggest that oral contraceptives have already prevented someovarian cancers anddeaths from the disease, and that over the next few decades the number of cancers prevented will rise to at least 30, per year.
Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23, women with ovarian cancer and 87, controls. Submitted by Lo-epid on 24 July - pm.
Tentamen (uitwerkingen)
Title Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23, women with ovarian cancer and 87, controls. DOI Tweets van AWOLimburg. News Project Leren en Verbeteren in verpleeghuiszorg genomineerd voor internationale prijs. Events Save the date: oratie prof.
Hilde Verbeek.]
One thought on “Oral contraceptive use and ovarian cancer case study answers”